UNDERWRITING AGREEMENT between CANCER GENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several UnderwritersUnderwriting Agreement • March 22nd, 2013 • Cancer Genetics, Inc • Services-medical laboratories • New York
Contract Type FiledMarch 22nd, 2013 Company Industry JurisdictionThe undersigned, Cancer Genetics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Cancer Genetics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
March 19, 2013 NNJCA Capital, LLCLetter Agreement • March 22nd, 2013 • Cancer Genetics, Inc • Services-medical laboratories
Contract Type FiledMarch 22nd, 2013 Company Industry
Empowering Personalized Cancer Treatment March 20, 2013 Meadows Office, L.L.C.Cancer Genetics, Inc • March 22nd, 2013 • Services-medical laboratories
Company FiledMarch 22nd, 2013 Industry
March 19, 2013 DAM Holdings, LLCCancer Genetics, Inc • March 22nd, 2013 • Services-medical laboratories
Company FiledMarch 22nd, 2013 Industry